ClearPoint Neuro, Inc. (CLPT) Debt Components
- 2026-06-30: Long-term DebtUSD $50.23M; Long-Term Debt, Maturity, after Year FiveUSD $51.97M; Long-term Debt, GrossUSD $51.97M; Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, NetUSD $1.74M.
- 2026-03-31: Long-term DebtUSD $49.64M; Long-Term Debt, Maturity, after Year FiveUSD $51.43M; Long-term Debt, GrossUSD $51.43M; Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, NetUSD $1.79M.
- 2025-12-31: Long-term DebtUSD $49.08M; Long-Term Debt, Maturity, after Year FiveUSD $50.91M; Long-term Debt, GrossUSD $50.91M; Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, NetUSD $1.83M.
- 2025-09-30: Long-term DebtUSD $29.20M; Long-Term Debt, Maturity, after Year FiveUSD $30.49M; Long-term Debt, GrossUSD $30.49M; Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, NetUSD $1.29M.
ClearPoint Neuro, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt USD | Long-Term Debt, Maturity, after Year Five USD | Long-term Debt, Gross USD | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD | Convertible Notes Payable, Current USD | Senior Notes, Current USD | Long-term Debt, Excluding Current Maturities USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Line of Credit Facility, Maximum Borrowing Capacity USD | Debt Instrument, Face Amount USD | Debt Instrument, Interest Rate, Stated Percentage pure | Debt Instrument, Convertible, Beneficial Conversion Feature USD | Debt Instrument, Increase (Decrease), Other, Net USD | Debt Instrument, Unamortized Discount, Current USD | Debt Instrument, Unamortized Discount USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $50.23M | $51.97M | $51.97M | $1.74M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $49.64M | $51.43M | $51.43M | $1.79M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $49.08M | $50.91M | $50.91M | $1.83M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $29.20M | $30.49M | $30.49M | $1.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $28.84M | $30.17M | $30.17M | $1.33M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $9.98M | (m) | $10.00M | (m) | $9.98M | (m) | (m) | $10.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $21.00K |
| 2024-03-31 | $9.96M | (m) | $10.00M | (m) | $9.96M | (m) | (m) | $10.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $36.00K |
| 2023-12-31 | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $9.95M | (m) | $10.00M | (m) | (m) | (m) | (m) | (m) | $10.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $51.00K |
| 2023-09-30 | $9.94M | (m) | $10.00M | (m) | (m) | (m) | (m) | (m) | $10.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $65.00K |
| 2023-06-30 | $9.92M | (m) | $10.00M | (m) | (m) | (m) | (m) | (m) | (m) | $10.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $79.00K |
| 2023-03-31 | $9.91M | (m) | $10.00M | (m) | (m) | (m) | (m) | (m) | (m) | $10.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $93.00K |
| 2022-12-31 | $9.89M | (m) | $10.00M | (m) | (m) | (m) | (m) | (m) | (m) | $10.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $107.00K |
| 2022-09-30 | $9.88M | (m) | $10.00M | (m) | (m) | (m) | (m) | (m) | (m) | $10.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $121.00K |
| 2022-06-30 | $9.87M | (m) | $10.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $10.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $135.00K |
| 2022-03-31 | $9.85M | (m) | $10.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $10.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $149.00K |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $0.00 | (m) | (m) |
| 2021-12-31 | $9.84M | (m) | $10.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $10.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $162.00K |
| 2021-09-30 | $17.61M | (m) | $17.79M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $17.79M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $175.00K |
| 2021-06-30 | $17.50M | (m) | $17.69M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $17.69M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $188.00K |
| 2021-03-31 | $24.52M | (m) | $25.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $25.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $582.00K |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $896.00K | (m) | (m) |
| 2020-12-31 | $21.28M | (m) | $25.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $25.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.72M |
| 2020-09-30 | $17.74M | $17.50M | $18.40M | (m) | (m) | (m) | $822.01K | (m) | $185.19K | $447.62K | $263.19K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $651.60K |
| 2020-06-30 | $17.71M | $17.50M | $18.40M | (m) | (m) | (m) | $599.32K | $73.98K | $446.50K | $375.51K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $685.90K |
| 2020-03-31 | $16.78M | $17.50M | $17.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $719.80K |
| 2019-12-31 | $2.07M | (m) | $2.84M | (m) | (m) | (m) | (m) | $2.84M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $765.07K |
| 2019-09-30 | $1.87M | (m) | $2.84M | (m) | (m) | (m) | (m) | (m) | $2.84M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $970.39K |
| 2019-06-30 | $1.87M | (m) | $3.00M | (m) | (m) | (m) | (m) | (m) | $3.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.13M |
| 2019-03-31 | $3.65M | (m) | $4.97M | (m) | (m) | (m) | (m) | (m) | $4.97M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.33M |
| 2018-12-31 | $3.48M | (m) | $4.97M | (m) | (m) | (m) | (m) | (m) | (m) | $4.97M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.48M |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.65M |
| 2018-06-30 | $3.33M | (m) | $4.97M | (m) | (m) | (m) | (m) | (m) | (m) | $4.97M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | $2.00M | (m) | (m) | $1.98M | (m) | (m) | (m) | $2.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $5.05M | (m) | $6.97M | (m) | (m) | $2.00M | (m) | (m) | $1.98M | $3.00M | (m) | (m) | $2.00M | (m) | (m) | (m) | (m) | (m) | $80.34K | $1.92M |
| 2017-12-31 | (m) | (m) | (m) | (m) | (m) | $2.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $4.92M | (m) | $6.97M | (m) | (m) | (m) | (m) | (m) | $1.98M | $3.00M | (m) | (m) | $2.00M | (m) | (m) | (m) | (m) | (m) | (m) | $2.02M |
| 2017-09-30 | $4.79M | (m) | $6.97M | (m) | (m) | (m) | (m) | (m) | $1.98M | $3.00M | (m) | (m) | $2.00M | (m) | (m) | (m) | (m) | (m) | (m) | $2.14M |
| 2017-06-30 | $4.69M | (m) | $6.97M | (m) | (m) | (m) | (m) | (m) | $1.98M | $3.00M | (m) | (m) | $2.00M | (m) | (m) | (m) | (m) | (m) | (m) | $2.24M |
| 2017-03-31 | $4.59M | (m) | $6.97M | (m) | (m) | (m) | (m) | (m) | $1.98M | $3.00M | (m) | (m) | $2.00M | (m) | (m) | (m) | (m) | (m) | (m) | $2.33M |
| 2016-12-31 | $4.49M | (m) | $6.97M | (m) | (m) | (m) | (m) | (m) | $1.98M | $3.00M | (m) | (m) | $2.00M | (m) | (m) | (m) | (m) | (m) | (m) | $2.42M |
| 2016-09-30 | $4.39M | (m) | $6.97M | (m) | (m) | (m) | (m) | (m) | $1.98M | $3.00M | (m) | (m) | $2.00M | (m) | (m) | (m) | (m) | (m) | (m) | $2.52M |
| 2016-06-30 | $6.05M | (m) | $8.72M | (m) | (m) | (m) | (m) | (m) | $3.73M | $3.00M | (m) | (m) | $2.00M | (m) | (m) | (m) | (m) | (m) | (m) | $2.54M |
| 2016-03-31 | $8.25M | (m) | $11.01M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.73M | $3.00M | $4.29M | (m) | (m) | (m) | (m) | (m) | (m) | $2.76M |
| 2015-12-31 | (m) | (m) | (m) | (m) | (m) | $4.22M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $64.83K | (m) |
| 2015-12-31 | $8.11M | (m) | $11.01M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.73M | $3.00M | $4.29M | (m) | (m) | (m) | (m) | (m) | (m) | $2.90M |
| 2015-09-30 | $8.00M | $3.00M | $11.01M | (m) | (m) | $4.17M | (m) | (m) | $4.29M | (m) | (m) | $3.73M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-3.02M |
| 2015-06-30 | $7.89M | $3.00M | $11.01M | (m) | (m) | $4.12M | (m) | (m) | $4.29M | (m) | (m) | $3.73M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-3.12M |
| 2015-03-31 | $11.01M | $3.00M | $7.79M | (m) | (m) | (m) | (m) | (m) | $4.29M | (m) | (m) | $3.73M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.23M |
| 2014-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $369.30K |
| 2014-12-31 | $11.01M | $3.00M | $7.69M | (m) | (m) | (m) | (m) | $0.00 | $4.29M | $0.00 | $0.00 | $3.73M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $383.20K | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $543.82K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-02-29 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 2 month · $383.20K | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $163.63K | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | $3.95M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3.50% | (m) | (m) | (m) | $2.78M |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $834.55K | (m) | (m) | (m) |
| 2010-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.00M | (m) | (m) | (m) | (m) | (m) |
| 2010-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3.50% | (m) | (m) | (m) | $2.78M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |